Short-term and long-term efficacies , adverse responses as well as the expression of nucleotide excision repair cross complementing 1 ( ERCC1 ) , ribonucleotide reductase subunit M1 ( RRM1 ) and lung resistance-related protein ( LRP ) in NSCLC tissues in both groups were assessed .